About Anagram
Inspired by the Patients We Aim to Help
Anagram Therapeutics is a clinical stage biopharmaceutical company developing novel, orally delivered enzyme therapeutics for the treatment of debilitating diseases caused by malabsorption syndromes and nutrient metabolism disorders which prevent the body from properly metabolizing or absorbing certain fats, sugars, proteins, vitamins, or other key nutrients.
Malabsorption syndromes and nutrient metabolism disorders affect infants, children, and adults with congenital diseases worldwide as well as others who might develop these conditions as comorbidities. Unfortunately, most of these debilitating, often-life threatening diseases are not properly treated or have no treatment at all. Anagram Therapeutics is committed to changing that.
Through revolutionary technology, we're redefining orally delivered enzyme therapeutics to make treatment for these difficult diseases easier to take, with more effective results.
At Anagram, we are united by a commitment to individuals and families affected by serious rare diseases. And we are driven to make a difference.
